RT Journal Article
T1 Engineering Anisotropic Meniscus: Zonal Functionality and Spatiotemporal Drug Delivery
A1 Abbadessa, Anna
A1 Crecente Campo, José
A1 Alonso Fernández, María José
K1 Meniscus
K1 Drug delivery
K1 Growth factors
K1 Zonal reconstruction
K1 Tissue engineering
K1 Anisotropic tissue regeneration
AB Human meniscus is a fibrocartilaginous structure that is crucial for an adequate performance of the human knee joint. Degeneration of the meniscus is often followed by partial or total meniscectomy, which enhances the risk of developing knee osteoarthritis. The lack of a satisfactory treatment for this condition has triggered a major interest in drug delivery (DD) and tissue engineering (TE) strategies intended to restore a bioactive and fully functional meniscal tissue. The aim of this review is to critically discuss the most relevant studies on spatiotemporal DD and TE, aiming for a multizonal meniscal reconstruction. Indeed, the development of meniscal tissue implants should involve a provision for adequate active molecules and scaffold features that take into account the anisotropic ultrastructure of human meniscus. This zonal differentiation is reflected in the meniscus biochemical composition, collagen fiber arrangement, and cell distribution. In this sense, it is expected that a proper combination of advanced DD and zonal TE strategies will play a key role in the future trends in meniscus regeneration
YR 2020
FD 2020
LK http://hdl.handle.net/10347/23900
UL http://hdl.handle.net/10347/23900
LA eng
NO This document is the preprint manuscript version of a published work that appeared in final form in Tissue Engineering Part B: Reviews, Copyright 2020, Mary Ann Liebert, Inc., publishers after peer review and technical editing by the publisher. To access the final edited and published work see: https://doi.org/10.1089/ten.teb.2020.0096
NO This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 814444 (MEFISTO); and from Xunta de Galicia’s Grupos de referencia competitiva (grant number ED431C 2017/09)
DS Minerva
RD 28 abr 2026